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Abstract: This review describes recent advances in biosensors of potential clinical applications. 
Biosensors are becoming increasingly important and practical tools in pathogen detection, 
molecular diagnostics, environmental monitoring, food safety control as well as in homeland 
defense. Electrochemical biosensors are particularly promising toward these goals arising due to 
several combined advantages including low-cost, operation convenience, and miniaturized devices. 
We review the clinical applications of electrochemical biosensors based on a few selected examples, 
including enzyme-based biosensors, immunological biosensors and DNA biosensors.
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Introduction
Biosensors are sensors that transduce bio-recognition processes into measurable 
signals via a physico-chemical transducer, with electronic and optical techniques as 
two major transducers (Fan et al 2005). The development of biosensors meets the 
rapidly increasing need for clinical diagnostics in these days. The use of biosensors 
brings about a combination of advantages. First, biosensors are highly sensitive. This 
is because biomolecules often possess high afﬁ  nity toward their targets, for example, 
antibodies captures antigens with a dissociation constant at the nanomolar scale, and 
DNA DNA interactions are even stronger than antigen-antibody. Second, biological 
recognition is usually very selective. An example is that enzyme and substrate are 
just like lock and key. Such high selectivity often leads to selective biosensors. Third, 
arising due to the development of modern electronic industry, it has been relatively 
easy to develop inexpensive, integrated and ready-to-use biosensor devices. These 
biological sensors certainly improve the ability to detect pathogens or perform genetic 
analysis in hospitals; more importantly, they are particularly useful for small clinics 
and even for point-of care analysis.
A variety of new strategies have been developed toward biosensors with clinical 
applications. In principle, biosensors are analytical devices composed of a biological 
recognition element and an optical/electronic transducer. The biological element is 
in charge of capturing analytes in solution and the transducer converts the binding 
event to a measurable signal variation. The type of biosensors can be categorized by 
the nature of recognition, that is, enzyme-based biosensors, immunological biosen-
sors, and DNA biosensors. Alternatively, based upon the type of transducers, there 
are electronic biosensors (electrical or electrochemical) (Fan et al 2003; Park et al 
2002), optical biosensors (ﬂ  uorescent, surface plasmon resonance, or Raman) (Taton 
et al 2000; Gaylord et al 2002; Xu et al 2005), and piezoelectric biosensors (quartz 
crystal microbalance) (Cooper et al 2001; Hook et al 2001). In this review, we will 
focus on electrochemical biosensors and introduce a few selected examples of enzyme, 
immunological and DNA biosensors as well as their potential clinical applications.International Journal of Nanomedicine 2006:1(4) 434
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Electrochemical sensing
Electrochemical techniques are particularly useful for bio-
logical sensing, where electrodes serve as either electron 
donors or electron acceptors. Extensive electrochemical 
studies have provided evidence that heterogeneous electron 
transfer between electrodes and surface-conﬁ  ned redox mol-
ecules, analogous to donor-acceptor pairs in homogeneous 
solutions, also abides by Marcus electron-transfer theory 
(Heeger 2000; Wosnick and Swager 2000; Adams et al 
2003). This means that small distance changes of surface-
conﬁ  ned redox molecules might induce large variations in 
heterogeneous electron-transfer rates that should translate 
into measurable changes of electrochemical signals. For 
example, Hellinga and co-workers proposed an electro-
chemical sensing strategy that exploits ligand-mediated 
hinge-bending motions in proteins. In their approach, a 
gold electrode was ﬁ  rst coated with self-assembled mono-
layer (SAM), which provides a versatile platform for site-
speciﬁ  c immobilization of proteins (Benson et al 2001). 
The maltose-binding protein (MBP) was then tethered to 
the gold electrode surface with a speciﬁ  c orientation such 
that the ruthenium (Ru(II)) redox reporter group is ﬁ  xed 
at a certain distance above the electrode. When the ligand 
maltose binds to the active site, it induces a hinge-bending 
motion of MBP that moves the Ru(II) reporter away from 
the electrode (Figure 1). This maltose-binding induced dis-
tance change induces concentration-dependent decrease of 
electrochemical signals, thus providing a way to electroni-
cally sensing maltose. They also demonstrated the use of 
this highly generalized sensing approach to detect diverse 
analytes with a family of proteins or enzymes that undergo 
ligand-binding induced conformational changes.
Enzyme-based biosensors
Glucose oxidase (GOD)-based biosensors were the ﬁ  rst 
biosensors ever reported, which was developed by Clark 
and Lyons in 1962 (Clark and Lyons 1962). Diabetes mel-
litus is characteristic of hyperglycemia, a chronically raised 
concentration of blood glucose. As a result, it is critical 
for diabetic patients to frequently monitor their glucose 
concentration in blood. This biosensor, and its more recent 
versions, takes the advantage of electrochemistry coupled 
with enzyme catalysis (Turner et al 1987). Clark’s biosensor 
was an electrode immobilized with GOD. In the presence 
of glucose, the oxidized form of GOD reacts with glucose 
and produces gluconic acid and reduced GOD, involving 
two electrons and two protons. This oxidation of glucose 
also consumes oxygen in solution since dissolved oxygen 
reacts with reduce GOD, thus forms hydrogen peroxide and 
oxidized GOD, and lowers oxygen pressure. As a result, the 
electrode can sense the glucose by electrochemically sensing 
oxygen with a Clark oxygen electrode. This kind of sensor 
is called “ﬁ  rst-generation” biosensor. This ﬁ  rst-generation 
biosensor was commercialized in the 1970s by the Yellow 
Springs Instrument Company (Ohio, USA).
The “second-generation” biosensor replaces the 
naturally existing substrate, oxygen, with artiﬁ  cial small 
redox molecules, which serve as the redox mediator and 
exchange electrons between electrodes and enzymes. 
A variety of soluble redox molecules, such as ferrocene, 
thionine, methylene blue, methyl viologen, were employed 
to improve the sensor performance, that is, sensitivity and 
signal-to-noise ratio. Initially these mediators were dissolved 
in solution. They obtain electrons from the electrodes and 
then these electrons are shuttled to the redox center of 
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Figure 1 A ruthenium-labeled maltose-binding protein (MBP) is site speciﬁ  cally attached to a self-assembled monolayer (SAM) coated gold electrode. The protein-ligand 
binding process mediates dependent changes between the Ru(II) redox reporter group and the surface-modiﬁ  ed gold electrode, which thereby alters current ﬂ  ow between 
the two components. Reprinted with permission from Benson DE, Conrad DW, de Lorimier RM, et al. 2001. Design of bioelectronic interfaces by exploiting hinge-bending 
motions in proteins. Science, 293:1641–4. Copyright 2001 © AAAS.International Journal of Nanomedicine 2006:1(4) 435
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enzymes, or vice versa. As a step further, immobilized 
mediators were proposed in order to develop reagentless 
biosensors. For example, Ruan et al reported a reagentless, 
solid-state sensor for hydrogen peroxide (Ruan et al 1998). 
They ﬁ  rst modiﬁ  ed gold electrodes with L-cysteine, and then 
multilayers of horseradish peroxidase (HRP) was linked to 
the amine group of cysteine by using glutaraldehyde, thio-
nine was further linked to the enzyme by the same linking 
chemistry. As a result, both the enzyme and the mediator were 
immobilized at the gold electrode, which could sensitively 
detect hydrogen peroxide in the test solution without further 
addition of reagents. An obvious advantage of this biosensor 
conﬁ  guration is that mediator is ﬁ  xed at the electrode surface, 
thus obviating the problem arising due to the diffusion. 
Heller reported an alternative approach that involved the 
use of redox polymers (Gao et al 2002; Rajagopalan and 
Heller 1997). They ﬁ  rst prepared a polymer doped with 
Os2+ complex. This kind of polymer serves as a “molecular 
wire” and exchanges electrons between the electrode and the 
enzyme. Therefore, they co-immobilized the Os-polymer and 
glucose oxidase on carbon electrode which produces sensitive 
response to the presence of glucose. By using these redox 
polymers, they were able to make nearly 100% immobilized 
enzyme molecules electroactive, which led to a glucose 
detection method with very high sensitivity.
The commercialization of the second-generation enzyme-
based biosensor was very successful. In 1987, MediSense was 
founded and they launched the pen-sized ExactechTM glucose 
sensors. This success has led to a revolution for health care of 
diabetic patients. They have been able to monitor their blood 
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Figure 2 (A) Assembly of Au-NPreconstituted GOx electrode by (a) the adsorption of Au-NPreconstituted GOx to a dithiol monolayer associated with a Au electrode and 
(b) the adsorption of Au-NPs functionalized with FAD on the dithiol-modiﬁ  ed Au electrode followed by the reconstitution of apo-GOx on the functional NPs (16). (B) A 
STEM image of GOx reconstituted with the Au-FAD hybrid NP. Arrows show Au clusters. Reprinted with permission from Xiao Y, Patolsky F, Katz E, et al. 2003. Plugging into 
enzymes: nanowiring of redox enzymes by a gold nanoparticle. Science, 299:1877–81. Copyright 2003 © AAAS.International Journal of Nanomedicine 2006:1(4) 436
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glucose concentration at home instead of going to the clinics. 
The MediSense and other later amperometric biosensor system 
consists of disposable, screen-printed carbon electrodes coated 
with GOD and mediators (test strips). Upon applying a drop-
let of blood on the test strip, the sensor begins to work and 
records amperometric response, which is converted to a digit 
displayed on LCD, representative of glucose concentration.
More recently, Xiao et al (2003)reported a new generation 
of glucose biosensor by designing a reconstructed GOD 
enzyme. They ﬁ  rst prepared apo-GOD that was free of 
the ﬂ  avin adenine dinucleotide (FAD) cofactor, then they 
functionalized a 1.4-nm gold nanoparticle with FAD 
and insert it into the apo-GOD by reconstruction. Such 
a reconstructed enzyme was linked to gold electrodes by 
using a dithiol monolayer (Figure 2). They showed that 
the electron transfer turnover of this artiﬁ  cial enzyme is 
as high as 5000 s–1, approximately 8-fold higher than the 
natural enzyme (700 s–1). In this system, gold nanoparticle 
acts as an electron relay for electrical wiring of the redox 
center of the enzyme. The glucose biosensor developed by 
Xiao et al represents a new direction in this area, which is 
free of any mediator and is highly sensitive. More recently, 
Willner’s group reported a modiﬁ  ed version of this sensor 
by using single wall carbon nanotubes (SWNTs) instead of 
gold nanoparticles and realized similarly high efﬁ  ciency 
(Patolsky et al 2004). While the commercialization of this 
technology is still not available, it is anticipated that it may 
further improve the state-of-the-art biosensors.
Immunological biosensor
Immunological biosensors rely on highly speciﬁ  c immunologi-
cal system, ie, antibody and antigen, to detect environmentally 
or clinically relevant targets. Immunological biosensors are 
actually a new version of enzyme-linked immunosorbent 
assay (ELISA), with reduced cost, improved speed and opera-
tion convenience, and comparable or even higher sensitivity. 
Electrochemical immunological biosensors are among the 
most popular ones. There are two types of immunological 
biosensor. First, a capture antibody is immobilized at the 
electrode, which captures speciﬁ  c target antigen. Signal 
transduction is realized via a secondary antibody tagged with 
redox molecules or enzymes. Second, an antigen is immobi-
lized at the electrode, which detects speciﬁ  c antibody.
Ju and co-workers developed an amperometric 
immunological biosensor for carcinoembryonic antigen 
(CEA) (Dai et al 2004). They co-immobilized thionine and 
HRP-labeled CEA antibody on a glassy carbon electrode, 
which were crosslinked with glutaraldehyde. HRP 
catalytically reduced hydrogen peroxide in solution, which 
was coupled to the electrode reaction of thionine, leading 
to a catalyzed signal. Capturing CEA partially blocked 
the redox center of HRP, thus leading to attenuation of 
amperometric signals.
Recently, Rusling and co-workers took advantage of 
SWNTs to improve the performance of immunological 
biosensors (Yu et al 2005) (Figure 3). They prepared vertically 
aligned arrays of SWNTs (SWNT forest) at pyrolytic graphite 
electrodes by using metal mediated self-assembly. Anti-HSA 
was then covalently linked to the carboxylated ends of SWNT 
forest by using EDC/NHS. After capturing HSA target, the 
electrode was further incubated with a secondary anti-HSA 
antibody labeled with HRP. Based on the catalytic signal of 
HRP for hydrogen peroxide, one can detect the HSA target in 
the test solution. Notably, the use of SWNT forests signiﬁ  cantly 
improved the detection sensitivity, which was approximately 
1 nM. This was possibly because of the enhanced electron 
transfer reactivity of HRP encapsulated in SWNT forests.
Immunological assays have become one of the most 
important clinical tools. Nevertheless, current assay methods, 
eg, ELISA, require large and expensive instrument as well 
as well-trained technicians. Electrochemical methods are 
well suited for the development of inexpensive, miniaturized 
and portable devices. As a result, it is highly attractive to 
develop electrochemical immunological biosensors in order 
to meet ﬁ  eld and point-of-care analysis. It is worthwhile to 
note that, similar to glucose biosensors, the use of disposable 
screen-printed electrodes should be critical toward this 
goal. Also of note, it is important to develop antibody 
microarrays based on electrochemistry in order to perform 
high-throughput (HTS) assays.
DNA biosensors
Detection of DNA hybridization events has been of signiﬁ  cant 
scientiﬁ  c and technological interest. This signiﬁ  cance has 
HRP
HRP
H2O2 H2O + 1/2 O2 
HRP HRP
Add Ab2
Ab1
Ab1
SWNT forest
sensor treated with
HSA
apply E measure I
Figure 3 Schematic diagram of HSA sandwich assay procedure. Reprinted with 
permission from Yu X, Kim SN, Papadimitrakopoulos F,  et al. 2005. Protein immunosensor 
using single-wall carbon nanotube forests with electrochemical detection of enzyme 
labels. Mol Biosyst, 1:70–8. Copyright 2003 © Royal Society of Chemistry.International Journal of Nanomedicine 2006:1(4) 437
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been particularly manifested by rapidly growing interest of 
chip-based clinical diagnosis (Gao et al 2002) Consequently, 
a variety of techniques have been developed over the years, 
including optical (Taton et al 2000; Gaylord et al 2002; Xu 
et al 2005), acoustic (Cooper et al 2001; Hook et al 2001), 
and electronic approaches (Boon et al 2000a; Patolsky 
et al 2001; Park et al 2002). Among them, the ﬂ  uorescent 
detection has dominated state of the art genosensors in past 
decades (Bowtell 1999; Winzeler et al 1999; Gao et al 2002). 
However, electrochemical methods, which have proven 
successful in simple chemical species especially metal ions, 
have attracted rapidly increasing attention in applications of 
sensing biologically related species (Fritz et al 2002; Kuhr 
2000; Willner 2002). Advantages of electronic detection 
include: 1) electrochemical detection is usually inexpensive 
while enables highly sensitive and rapid screening (Bard 
and Faulkner 2001); 2) unlike ﬂ  uorophores that often have 
“photo-bleaching” problems, many electroactive labels, eg, 
metallocenes, are stable and environmentally insensitive; 
3) “multi-color” labeling has been possible by suitable 
molecular design and synthesis that produce a spectrum of 
derivatives, each having a unique redox potential (Brazill et al 
2001); 4) the highly developed silicon industry has paved the 
road to mass-production of integrated circuits which renders 
electronic detection especially suitable and compatible with 
microarray-based technologies; 5) the rapidly developing 
interfacial science and technology has been unraveling mys-
teries in precisely controlling surface properties which acts 
as one of the major barricades in bioelectronic applications 
(Mrksich and Whitesides 1996; Yu et al 2001; Whitesides 
and Grzybowski 2002).
DNA itself is electrochemically silent at moderate 
applied voltages while severe interferences are expected 
at high voltages that enable oxidation/reduction of DNA 
bases (Palecek and Jelen 2002). Millan was the ﬁ  rst that 
proposed sequence-selective DNA target detections based 
on electroactive hybridization indicators, which provide 
electronic signals as well as discrimination between double 
and single stranded DNA (Millan and Mikkelsen 1993). In an 
attempt to reduce high background deriving from the minor 
binding of hybridization indicators to ssDNA, “sandwich” 
type detections has been proposed (Ihara et al 1996; Umek 
et al 2001; Yu et al 2001). Besides an immobilized DNA 
probe, a DNA strand possessing an electroactive label has 
been introduced to act as the signaling molecule. Similarly, 
Park et al (2002) have developed an array-based electrical 
DNA detection with nanoparticle probes which demonstrates 
high sensitivity and selectivity. Thorp (2003) developed a 
technology based on the relatively high oxidation activity of 
guanine and its facilitation by exogenous redox catalysts. The 
ds/ss discrimination is achieved by the fact that guanine in 
duplexes, due to the steric effect, has relatively low electron 
transfer reactivity. This method is highly sensitive in detec-
tion of PCR products however relatively poor in discrimina-
tion of hybridization events. Moreover, this method is only 
possible at ITO surfaces till now the high oxidation potential 
still excludes the use of gold.
In spite of the progress, it is still highly important to 
develop an all-in-one (ie, reagentless) sensor that directly 
signals upon target capturing (ie, obviating further treatment 
with either hybridization indicators or signal molecules). 
DNA or RNA aptamers provide a viable means to this end. 
Aptamers are well-structured DNA or RNA which, as well 
as natural enzymes, possess high afﬁ  nity and selectivity to 
speciﬁ  c targets whereas demonstrate superior robustness to 
fragile enzymes (Chang and Varani 1997; Burgstaller et al 
2002). They have emerged as a very promising therapeutic 
and diagnostic tool (Turner et al 1987). In the meantime, 
the well developed in vitro selection has been able to pro-
duce aptamers for virtually any given target (Turner et al 
1987; Grifﬁ  ths and Tawﬁ  k 2000). Given these advantages, 
the oligonucleotide aptamers have been anticipated to be 
the next-generation biosensing elements (Robertson and 
Ellington 1999; Sullivan 2002). Fan et al (2003) employed 
a simple structured, hairpin-like DNA with an electroactive 
label (electronic DNA hairpin) as the building block to detect 
hybridization events (Figure 4). Hairpin-like DNA has been 
an extremely interesting aptamer that forms the basis of 
ﬂ  uorescent “molecular beacons” for homogeneous hybrid-
ization detection. The DNA sequence have been designed 
such that this “beacon” is in the close state in the absence of 
targets while will be “turned on” when it meets its speciﬁ  c 
gene target. The existence of the stem-loop structure in the 
design provides an on/off switch as well as a stringency 
to discriminate single mismatch in DNA hybridization. In 
this electronic DNA hairpin, a thiolated terminus provides 
a sticky end to the gold surface while a ferrocene tag at the 
other end transducts electronic signals. The initial hairpin 
localizes the ferrocene proximal to the electrode surface, thus 
allowing interfacial electron transfer. After hybridization, the 
formation of the linear duplex structure disrupts the hairpin 
and forces apart the ferrocene and the electrode. This signiﬁ  -
cant distance change (up to a few nm) effectively blocked 
the interfacial electron transfer and leads to the diminution 
of corresponding electrochemical current signals (Figure 5). 
This strategy offers the opportunity to identify 10 pM DNA International Journal of Nanomedicine 2006:1(4) 438
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targets. More importantly, such a design takes the advantage 
of integrating the capturing part (probe sequence) and the 
signaling part (electroactive species) within a single surface-
conﬁ  ned hairpin structure. Therefore, in contrast to most 
previously proposed solid-state DNA sensors, this design is 
effectively reagentless, ie, aside from DNA targets, no exog-
enous reagent is necessary during the recognition process. 
This provides the basis to construct a portable, continuous 
DNA analyzer that might be useful in medical and military 
applications (Palecek 2004; Thorp 2003).
DNA double helix has been suggested to be a medium for 
long-range electron transfer (ET) via its base stacking (Kelley 
and Barton 1999; Schuster 2000). Although this issue has 
been of long-time debate, Barton and coworkers have elec-
trochemically proven that well-oriented DNA ﬁ  lms at gold 
electrode allows long-range electron transfer and that such 
ET is extremely sensitive to base stacking pertubations such 
as mismatches (Boon et al 2003; Kelley et al 1999). They 
observed that electroactive intercalators such as methylene 
blue (MB) could be efﬁ  ciently reduced at an electrode modi-
ﬁ  ed with fully matched DNA duplex. However, the presence 
of just a single mismatch converts the wire-like ET medium to 
an insulator, which completely disrupts ET between the MB 
and the electrode. Such a difference can be readily read out 
via cyclic voltammetric or coulometric assays, which forms 
the basis of a rapid DNA mutation screening sensor (Boon 
et al 2000b; Drummond et al 2003). Barton and coworkers 
further showed that the sensitivity of this approach could be 
improved by electrocatalysis. Addition of ferricyanide in 
solution repetitively pulls electrons from electrochemically 
reduced MB which ampliﬁ  es electron ﬂ  ow through the DNA 
double helix (Boon et al 2000b). This allows detection of 
∼108 DNA molecules with a 30-μm electrode. Parallel to 
DNA detection, they also constructed DNA-based sensor 
to detect DNA binding proteins (Boon et al 2002). Certain 
DNA-binding proteins or enzymes are known to interfere 
with DNA base pair stacking, thus converting DNA double 
helix from efﬁ  cient ET wires to insulators. Based on the 
similar sensing strategy, they developed a sensitive way 
to electrically assay a variety of DNA-binding proteins. 
Importantly, these sensors effectively discriminate against 
proteins that bind to DNA albeit do not perturb base stacking 
(Boon et al 2002). This undoubtedly conﬁ  rms that the signal 
cut-off upon protein binding is due to the alteration of base 
stacking-related ET medium.
The future of clinical biosensors
Despite the rapid progress in biosensor development, clinical 
applications of biosensors are still rare, with glucose monitor 
as an exception. This is in sharp contrast to the urgent need 
in small clinics and point-of-care tests. We believe the 
following requirements are necessary. First, high sensitivity: 
Sensitivity improvement is an ever-lasting goal in biosensor 
development. It is true that the requirement for sensitivity 
varies from case to case. For example, one does not need 
a very high sensitivity for glucose detection since glucose 
concentration is high in blood. This is actually part of reason 
for the success of glucose monitors. However, in many cases 
Au electrode
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denaturation/re-annealing
+cDNA T e
Figure 4 A stem loop oligonucleotide possessing terminal thiol and a ferrocene group is immobilized at a gold electrode through self-assembly. In the absence of target, the 
stem loop structure holds the ferrocene tag into close proximity with the electrode surface, thus ensuring rapid electron transfer and efﬁ  cient redox of the ferrocene label. On 
hybridization with the target sequence, a large change in redox currents is observed, presumably because the ferrocene label is separated from the electrode surface. Reprinted 
with permission from Fan C, Plaxco KW, Heeger AJ. 2003. Electrochemical interrogation of conformational changes as a reagentless method for the sequence-speciﬁ  c detection 
of picomolar DNA. Proc Natl Acad Sci U S A, 100:9134–7. Copyright 2003 © The National Academy of Sciences of the United States of   America.International Journal of Nanomedicine 2006:1(4) 439
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it is very important to develop highly sensitive biosensors, 
optimally single-molecule detection, in order to meet the 
requirement of molecular diagnostics and pathogen detection. 
Second, high selectivity: This might a major barricade in the 
application of biosensors. Most biosensors reported in the 
literature work very well in laboratories, however may meet 
series problems in test real samples. As a result, it is essential 
to develop novel surface modiﬁ  cation approaches in order to 
avoid non-speciﬁ  c adsorption at surfaces. Third, multiplexing 
is critical for saving assay time, which is especially important 
for assays performed in laboratories or clinics. Thus it is 
important to develop high-density electrode arrays as well as 
electrochemical instrument that can simultaneously perform 
a large number of assays. Forth, it is important to develop 
miniaturized biosensors in order to increase portability, thus 
meet the requirement of ﬁ  eld and point-of-care test. Fifth, an 
ideal biosensor should be integrated and highly automated. 
Current lab-on-a-chip technologies (microﬂ  uidics) offer a 
solution toward this goal. We can expect that successful 
biosensors in the future may incorporate all these features, 
and can conveniently detect minute targets within a short 
period.
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